相关实验视频

Updated: Jan 18, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

胆道癌的免疫检查点抑制剂:谁受益,下一步是什么?

Lucía Ceniceros¹, Manuel de La Torre², Ana Landa Magdalena¹

¹Liver Unit, Cancer Center Clinica Universidad de Navarra (CCUN), Program in Solid Tumors (CIMA), Universidad de Navarra, Clínica Universidad de Navarra, 31008 Pamplona, Spain.

|September 13, 2025

概括

免疫检查点抑制剂 (ICI) 在胆道癌症 (BTC) 中表现出适度的影响. 研究正在探索新的组合和患者选择策略,以改善这种侵袭性恶性瘤的结果.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
癌症生物学癌症生物学

背景情况:

胆道癌 (BTC) 是一种罕见的,具有显著瘤和免疫微环境异质性的侵袭性恶性瘤.
大多数患者患有晚期疾病,面临有限的治愈治疗选择.
目前的免疫检查点抑制剂 (ICI) 对BTC患者提供了适度的益处.

研究的目的:

审查ICI在胆道癌症中的当前作用和不断变化的格局.
讨论瘤异质性如何影响免疫疗法治疗反应.
探索未来优化患者选择BTC治疗的战略.

主要方法:

本综述综合了BTC中免疫检查点抑制剂的当前文献.
它分析了瘤生物学和免疫微环境异质性的影响.
它检查了关于组合疗法和患者分层的正在进行的研究.

主要成果:

虽然ICI已经改变了其他癌症,但它们在BTC中的有效性仍然有限.
组合疗法在先进的BTC中显示了增量生存改善.
瘤异质性对有效的免疫疗法构成了重大挑战.

结论:

在BTC中优化ICI治疗需要解决瘤异质性的问题.
未来的研究应该专注于新的组合策略和精确的患者选择.
改善高级BTC治疗结果仍然是一个关键的未满足需求.

关键词:

胆道癌症是胆道癌症.免疫检查点抑制剂免疫检查点抑制剂治疗结果治疗结果

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...